Sulfonterol

This classification denotes a beta-adrenergic agonist with the molecular formula C14H23NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z540ZT2MI6, chemically known as benzenemethanol, alpha-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-3-((methylsulfonyl)methyl)- but generally known as sulfonterol, which bears US NIH Compound Identifier 170373. European Medicines Agency schedules Sulfonterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10741MIG. The term SULFONTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). SULFONTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulfonterol under HS 29309085 and SITC 51549. As of Q4 2014, SULFONTEROL remains the US FDA Preferred Term for this commodity. Sulfonterol bears US NLM identifiers UMLS ID C0075584 and NCI Concept Code C76549. SMILES: S(=O)(=O)(CC1CC(C(O)CNC(C)(C)C)CCC1O)C.